دورية أكاديمية
Mass immunization with inactivated polio vaccine in conflict zones--Experience from Borno and Yobe States, North-Eastern Nigeria.
العنوان: | Mass immunization with inactivated polio vaccine in conflict zones--Experience from Borno and Yobe States, North-Eastern Nigeria. |
---|---|
المؤلفون: | Shuaibu FM; National Polio Emergency Operation (EOC), Abuja, Nigeria., Birukila G; UNICEF, Maiduguri, Borno State, Nigeria., Usman S; Collaboration Resources for Child Health (CORE) Group, Nigeria., Mohammed A; National Primary Health Care Development Agency, Abuja, Nigeria., Galway M; Bill & Melinda Gates Foundation, Abuja, Nigeria., Corkum M; National Primary Health Care Development Agency, Abuja, Nigeria.; UNICEF, Abuja, Nigeria., Damisa E; National Polio Emergency Operation (EOC), Abuja, Nigeria., Mkanda P; Bill & Melinda Gates Foundation, Abuja, Nigeria.; World Health Organization, Abuja, Nigeria., Mahoney F; UNICEF, Abuja, Nigeria.; US Centers for Disease Control and Prevention (CDC)., Wa Nganda G; US Centers for Disease Control and Prevention (CDC)., Vertefeuille J; US Centers for Disease Control and Prevention (CDC)., Chavez A; Bill & Melinda Gates Foundation, Abuja, Nigeria.; World Health Organization, Abuja, Nigeria., Meleh S; World Health Organization, Abuja, Nigeria.; Polio Emergency Operation Center, Borno State, Nigeria., Banda R; Bill & Melinda Gates Foundation, Abuja, Nigeria.; World Health Organization, Abuja, Nigeria., Some A; World Health Organization, Abuja, Nigeria.; Polio Emergency Operation Center, Borno State, Nigeria., Mshelia H; World Health Organization, Abuja, Nigeria.; Polio Emergency Operation Center, Borno State, Nigeria., Umar AU; National Primary Health Care Development Agency, Abuja, Nigeria.; UNICEF, Abuja, Nigeria., Enemaku O; National Primary Health Care Development Agency, Abuja, Nigeria.; UNICEF, Abuja, Nigeria., Etsano A; National Polio Emergency Operation (EOC), Abuja, Nigeria. |
المصدر: | Journal of public health policy [J Public Health Policy] 2016 Feb; Vol. 37 (1), pp. 36-50. Date of Electronic Publication: 2015 Nov 05. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Palgrave Macmillan Country of Publication: England NLM ID: 8006508 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1745-655X (Electronic) Linking ISSN: 01975897 NLM ISO Abbreviation: J Public Health Policy Subsets: MEDLINE |
أسماء مطبوعة: | Publication: 2005- : Basingstoke, England : Palgrave Macmillan Original Publication: [Burlington, Vt., Journal of Public Health Policy, inc.] |
مواضيع طبية MeSH: | Warfare*, Mass Vaccination/*statistics & numerical data , Poliomyelitis/*prevention & control , Poliovirus Vaccine, Inactivated/*administration & dosage, Child, Preschool ; Humans ; Infant ; Infant, Newborn ; Nigeria ; Program Evaluation |
مستخلص: | The use of Inactivated Polio Vaccine (IPV) in routine immunization to replace Oral Polio Vaccine (OPV) is crucial in eradicating polio. In June 2014, Nigeria launched an IPV campaign in the conflict-affected states of Borno and Yobe, the largest ever implemented in Africa. We present the initiatives and lessons learned. The 8-day event involved two parallel campaigns. OPV target age was 0-59 months, while IPV targeted all children aged 14 weeks to 59 months. The Borno state primary health care agency set up temporary health camps for the exercise and treated minor ailments for all. The target population for the OPV campaign was 685,674 children in Borno and 113,774 in Yobe. The IPV target population for Borno was 608,964 and for Yobe 111,570. OPV coverage was 105.1 per cent for Borno and 103.3 per cent for Yobe. IPV coverage was 102.9 per cent for Borno and 99.1 per cent for Yobe. (Where we describe coverage as greater than 100 per cent, this reflects original underestimates of the target populations.) A successful campaign and IPV immunization is viable in conflict areas. |
References: | Wkly Epidemiol Rec. 2013 Apr 12;88(15):153-60. (PMID: 23620907) Ann Clin Res. 1982 Dec;14(5-6):204-12. (PMID: 7171229) Soc Sci Med. 2006 Oct;63(7):1857-69. (PMID: 16765498) Science. 2014 Aug 22;345(6199):922-5. (PMID: 25146288) Lancet. 2014 Oct 25;384(9953):1505-12. (PMID: 25018120) Can J Public Health. 1989 Sep-Oct;80(5):363-8. (PMID: 2804867) Int J Prev Med. 2011 Jul;2(3):117-21. (PMID: 21811651) JAMA. 1961 Apr 1;175:1159-62. (PMID: 13769273) MMWR Morb Mortal Wkly Rep. 2014 Mar 21;63(11):237-41. (PMID: 24647400) J Immunol. 1999 Apr 15;162(8):5011-8. (PMID: 10202050) Int J Epidemiol. 2000 Aug;29(4):757-63. (PMID: 10922356) Glob Public Health. 2013;8(10):1138-50. (PMID: 24294986) MMWR Morb Mortal Wkly Rep. 1988 Apr 29;37(16):257-9. (PMID: 3128726) J Infect Dis. 2010 May 15;201(10):1535-43. (PMID: 20367459) |
معلومات مُعتمدة: | 001 International WHO_ World Health Organization |
المشرفين على المادة: | 0 (Poliovirus Vaccine, Inactivated) |
تواريخ الأحداث: | Date Created: 20151106 Date Completed: 20161213 Latest Revision: 20220129 |
رمز التحديث: | 20231215 |
DOI: | 10.1057/jphp.2015.34 |
PMID: | 26538455 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1745-655X |
---|---|
DOI: | 10.1057/jphp.2015.34 |